Abstract
Background
We have investigated the role of protein kinase C (PKC) in the mechanism of cerebral vasospasm, and showed the pivotal roles of PKC isoforms (PKCδ and α) in that mechanism. On the other hand, protein tyrosine kinase (PTK) is also activated during the maintenance of cerebral vasospasm. The aim of this study is to clarify the relationship between PKC and PTK activations in the mechanism of cerebral vasospasm, and discuss what we know and what we do not know about the roles of cross-talk mechanisms in the signal transduction systems.
Method
The experimental animal model is a “two-haemorrhage” canine model. In situ treatments using specific PKCδ and PKCα inhibitors were examined to clarify the roles of each in the mechanism of cerebral vasospasm. Using vasospastic canine basilar arteries, phosphorylation rates of tyrosine-residue of PKC isoforms were examined.
Findings
PKCδ was activated from day 4 to day 7, and PKCα on day 7. A specific PKCδ inhibitor inhibited the initiation of cerebral vasospasm, but not the maintenance. A specific PKCα inhibitor did not inhibit the initiation, but did the cerebral vasospasm in its maintenance phase. Both activations were down-regulated on day 14. PTK was activated from day 7 and continued until day 14. Although no phosphorylation of tyrosine-residue of PKCα was observed, tyrosine-residue of PKCδ was significantly phosphorylated, and the time-course and extent of PTK activation and phosphorylation of PKCδ tyrosine-residue correlated well. The vasospastic canine basilar arteries showed phenotypic changes from day 7 to day 14.
Conclusions
PKCδ plays a pivotal role in the initiation of cerebral vasospasmafter SAH, but not its maintenance. However, the translocation of PKCδ to the membrane fraction continued until day 7. These results indicate that the activated PKCδ by phosphorylation of its tyrosine-residue might contribute to the phenotypic changes of cerebral vasospastic arteries, and sustain the vasospasmover aweek. To clarify the exact crosstalk mechanisms in these signal transduction systems is extremely important to understand the mechanisms of cerebral vasospasm.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nishizawa S, Obara K, Nakayama K, Koide M, Yokoyama T, Yokota N, Ohta S (2000) Protein kinase Cδ and α are involved in the development of vasospasm after subarachnoid hemorrhage. Eur J Pharmacol 398: 113–119
Nishizawa S, Obara K, Koide M, Nakayama K, Ohta S, Yokoyama T (2003) Attenuation of canine cerebral vasospasm after subarachnoid hemorrhage by protein kinase C inhibitors despite augmented phosphorylation of myosin light chain. J Vasc Res 40: 168–179
Obara K, Nishizawa S, Koide M, Nozawa K, Mitate A, Ishikawa T, Nakayama K (2005) Interactive role of protein kinase Cδ with Rhokinase in the development of cerebral vasospasm in a caninehemorrhage model. J Vasc Res 42: 67–76
Nishizawa S, Laher I (2005) Signaling mechanisms in cerebral vasospasm. Trends Cardiovasc Med 15: 24–34
Koide M, Nishizawa S, Ohta S, Yokoyama T, Namba H (2002) Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage: from protein kinase C to protein tyrosine kinase. Neurosurgery 51: 1468–1476
Li W, Mischak H, Yu JC, Wang LM, Mushinski JF, Heidaren MA, Pierce JH (1994) Tyrosine phosphrylation of protein kinase C-δ in response to its activation. J Biol Chem 269: 2349–2352
Gschwendt M, Kielbassa K, Kittstein W, Marks F (1994) Tyrosine phosphorylation of protein kinase Cδ from porcine spleen by src in vitro. FEBS Lett 347: 85–89
Soltoff SP, Toker A (1995) Carbachol, substance P, and phorbol ester promote the tyrosine phosphorylation of protein kianse Cδ in salivary gland epithelia cells. J Biol Chem 270: 13490–13495
Li W, Li W, Chen XH, Kelly CA, Alimandi M, Zhang J, Chen Q, Bottaro DP, Pierce JH(1996) Identification of tyrosine 187 as a protein kinase C-δ phosphorylation site. J Biol Chem 271: 26404–26409
Denning MF, Dlugosz AA, Threadgrill DW, Magnuson T, Yuspa SH (1996) Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase Cδ. J Biol Chem 271: 5325–5331
Lu Z, Hornia A, Jiang YW, Zang Q, Ohno S, Foster DA (1997) Tumor promotion by depleting cells of protein kinase Cδ. Mol Cell Biol 17: 3418–3428
Song JS, Swann PG, Szallasi Z, Blank Z, Blumberg PM, Rivera J (1998) Tyrosine phosphorylation-dependent and-independent association of protein kinase C-δ with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-δ. Oncogene 16: 3357–3368
Kronfeld H, Kazimirsky G, Lorenzo PS, Garfield SH, Blumberg PM, Brodie C (2000) Phosphorylation of protein kinase Cδ on distinct tyrosine residues regulates specific cellular functions. J Biol Chem 275: 35491–35498
Stetak A, Lankenau A, Vantus T, Csermely P, Ulrich A, Keri G (2001) The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCδ and c-Src. Biochem Biophys Res Co 285: 483–4888
Tapia JA, Garcia-Marin LJ, Jensen RT (2003) Cholecystokininstimulated protein kinase C-δ kinase activation, tyrosine kinase phosphoryaltion, and translocation are mediated by Src tyrosine kinases in pancreatic acinar cells. J Biol Chem 278: 35220–35230
Yamaguchi-Okada M, Nishizawa S, Koide M, Nonaka Y (2005) Biomechanical and phenotypic changes in the vasospastic canine basilar artery after subarachoid hemorrhage. J Appl Physiol 99: 2045–2052
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag
About this paper
Cite this paper
Nishizawa, S., Koide, M., Yamaguchi-Okada, M. (2008). The roles of cross-talk mechanisms in the signal transduction systems in the pathophysiology of the cerebral vasospasm after subarachnoid haemorrhage — what we know and what we do not know. In: Kırış, T., Zhang, J.H. (eds) Cerebral Vasospasm. Acta Neurochirurgica Supplement, vol 104. Springer, Vienna. https://doi.org/10.1007/978-3-211-75718-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-211-75718-5_11
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-75717-8
Online ISBN: 978-3-211-75718-5
eBook Packages: MedicineMedicine (R0)